[1] |
ZHANG Y, ZOU J, ZHAO X, et al. Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system[J]. J Gen Virol, 2019, 100(1): 69. doi: 10.1099/jgv.0.001180 |
[2] |
PAUL D, MADAN V, RAMIREZ O, et al. Glycine zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles[J]. J Virol, 2018, 92(4): e01890. |
[3] |
KONG L, LI S, HUANG M, et al. The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication[J]. PLoS One, 2015, 10(4): e123190. |
[4] |
LI S, YE L, YU X, et al. Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-κB activation[J]. Virology, 2009, 391(2): 257. doi: 10.1016/j.virol.2009.06.039 |
[5] |
HU B, LI S, ZHANG Z, et al. HCV NS4B targets Scribble for proteasome-mediated degradation to facilitate cell transformation[J]. Tumour Biol, 2016, 37(9): 12387. doi: 10.1007/s13277-016-5100-4 |
[6] |
张战锋, 谢在春, 庞志宇, 等. NF2基因在丙肝病毒非结构蛋白4B调节细胞周期中的作用[J]. 基础医学与临床, 2019, 39(9): 1289. doi: 10.3969/j.issn.1001-6325.2019.09.014 |
[7] |
JANSE VRH, YANG X. The Hippo pathway and cancer immunity: friend or foe?[J]. Oncoscience, 2018, 5(3/4): 49. |
[8] |
TAHA Z, JANSE VRH, YANG X. The Hippo pathway: immunity and cancer[J]. Cancers(Basel), 2018, 10(4): 94. |
[9] |
HONG AW, MENG Z, PLOUFFE SW, et al. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation[J]. Genes Dev, 2020, 34(7/8): 511. |
[10] |
MENG Z, MOROISHI T, GUAN KL. Mechanisms of Hippo pathway regulation[J]. Genes Dev, 2016, 30(1): 1. doi: 10.1101/gad.274027.115 |
[11] |
PETRILLI AM, FUSE MA, DONNAN MS, et al. A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2[J]. Am J Transl Res, 2014, 6(5): 471. |
[12] |
GUAN Y, GONG Z, XIAO T, et al. Knockdown of miR-572 suppresses cell proliferation and promotes apoptosis in renal cell carcinoma cells by targeting the NF2/Hippo signaling pathway[J]. Int J Clin Exp Pathol, 2018, 11(12): 5705. |
[13] |
MIA MM, CHELAKKOT-GOVINDALAYATHIL AL, SINGH MK. Targeting NF2-Hippo/Yap signaling pathway for cardioprotection after ischemia/reperfusion injury[J]. Ann Transl Med, 2016, 4(24): 545. doi: 10.21037/atm.2016.11.85 |
[14] |
PETRILLI AM, GARCIA J, BOTT M, et al. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells[J]. Oncotarget, 2017, 8(19): 31666. doi: 10.18632/oncotarget.15912 |
[15] |
BELTRAMI S, KIM R, GORDON J. Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator[J]. Anticancer Res, 2013, 33(1): 1. |